With Myopiax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from With Myopiax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In With Myopiax Today - Breaking & Trending Today

Dopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia

Published: May 28, 2024

Safe and Tolerable: MyopiaX-1 proof-of-concept clinical trial (NCT04967287) supports MyopiaX's excellent safety and tolerability profile with no untoward safety events. Novel Approach: Dopavision's

Source: finanznachrichten.de

Related Topics:

Novartis PharmaDopavision GmbIan FlitcroftMark WuttkeAbabax HealthBoehringer Ingelheim Venture FundGerman Federal Ministry Of EducationBusiness WireCoordinating InvestigatorWith MyopiaxSeventure PartnersGerman Federal MinistryExecutive OfficerIhr Portfolio